The treatment is an emulsion of dodecafluoropentane that helps transfer oxygen into the tumor when administered intravenously, according to a June 26 system news release.
The increased oxygen delivery to hypoxic glioblastoma tissue could boost the effectiveness of radiation and chemotherapy, according to the release.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
